Drug Shortage Report for JAMP-SOLIFENACIN
Report ID | 162505 |
Drug Identification Number | 02424347 |
Brand name | JAMP-SOLIFENACIN |
Common or Proper name | Solifenacin Succinate Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | SOLIFENACIN SUCCINATE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 (bottle) |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-31 |
Estimated end date | 2024-01-31 |
Actual end date | 2024-04-15 |
Shortage status | Resolved |
Updated date | 2024-04-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2024-04-17 | French | Compare |
v15 | 2024-04-17 | English | Compare |
v14 | 2023-09-26 | French | Compare |
v13 | 2023-09-26 | English | Compare |
v12 | 2022-12-09 | French | Compare |
v11 | 2022-12-09 | English | Compare |
v10 | 2022-11-09 | French | Compare |
v9 | 2022-11-09 | English | Compare |
v8 | 2022-10-07 | French | Compare |
v7 | 2022-10-07 | English | Compare |
v6 | 2022-09-19 | French | Compare |
v5 | 2022-09-19 | English | Compare |
v4 | 2022-09-16 | French | Compare |
v3 | 2022-09-16 | English | Compare |
v2 | 2022-06-13 | French | Compare |
v1 | 2022-06-13 | English | Compare |
Showing 1 to 16 of 16